+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Implantable Biomaterials Global Market Report 2023

  • PDF Icon

    Report

  • 250 Pages
  • February 2023
  • Region: Global
  • The Business Research Company
  • ID: 5733770

Quick Summary:

In the rapidly evolving health technology industry, the implantable biomaterials market has emerged as a critical area of growth and innovation. These unique materials, ranging from metallics to ceramics to polymers and natural materials, are paving the way forward for breakthroughs in medical procedures, revolutionizing the way we approach treatments for myriad health conditions.

This exclusive market research report presents an unparalleled opportunity to gain valuable insights into this surging sphere. With a focus on 'factory gate' values and an extensive geographic coverage, this report will enable you to comprehend the trends and potential for enhancement in the industry. In-depth analysis of the different segments within the market, including the key players, aid in strategizing and keeping abreast of the opportunities within this domain, thereby empowering informed business decisions vital for future growth and success.

The global implantable biomaterials market is expected to grow from $101.91 billion in 2021 to $113.64 billion in 2022 at a compound annual growth rate (CAGR) of 11.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, causing inflation across goods and services effecting many markets across the globe. The market is expected to grow to $180.87 billion in 2026 at a CAGR of 12.3%.

The implantable biomaterial market consists of sales of glass-ceramic and bioactive glasses and calcium phosphate cements. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

An implantable biomaterial is a natural or synthetic material that is used in medical applications to support, enhance, or replace damaged tissue or a biological structure.

North America was the largest region in the implantable biomaterials market in 2022. Western Europe was the second largest region in the implantable biomaterials market. The regions covered in the implantable biomaterials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The main materials in the implantable biomaterials are the materials such as metallic, ceramic, polymers, and natural. Metallic implants in implantable biomaterials refer to the component that is widely selected for orthopedic prosthesis over polymeric biomaterials and traditional ceramic materials and is used for the enhancement of biological activities. The various applications include dental, cardiovascular, ophthalmology, orthopedic, and others. These are used in hospitals, ambulatory surgical centres, and specialty clinics.

The allocation of funds by government organizations in the development of new biomaterials [SR1] contributed to the implantable biomaterials market growth. For instance, Drexel University granted USD 200,000 to the National Science Foundation for research on biomaterial-mediated control over macrophage behavior that affects biomaterial vascularization. The support from government organizations in the development of new biomaterials will drive the implantable biomaterials market.

Limitations of biomaterial-based products are a major challenge for the implantable biomaterials market. For instance, metal biomaterials can corrode due to chemical reactions within the body such as enzymes and acids or it can also cause some metal ion toxicity in the body. Polymer biomaterial implants have intensive interaction with the body and can lead to wear and tear and can absorb the important nutrients and water from the blood. Some biomaterial implants can also minimize bone ingrowth or sometimes, implants can loosen over time and become dislodged. These reactions that biomaterials have with the body restrain their use thereby negatively impacting the implantable biomaterials market's growth.

Major companies in the implantable biomaterials market are implementing 3D printing of biomaterials in manufacturing. For instance, Evonik is producing 3D printable biomaterials for medical technology that are used for manufacturing medical implants with permanent body contact and temporary body contact line of bioresorbable filaments and powders. Implants with permanent body contact are based on Vestakeep Peek, and with the temporary body, contact is based on Resume.

In April 2022, Integer Holdings Corporation, a US-based medical device company, acquired Connemara Biomedical Holdings Teoranta for an undisclosed amount. The acquisition would bring implantable biomaterial technology to Integer’s control and help its growth. Connemara Biomedical Holdings Teoranta is a Ireland-based manufacturer of biomaterials for cardiovascular implants.

The countries covered in the implantable biomaterials market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and USA.

The market value is defined as the revenues that enterprises gain from goods and/or services sold within the specified market and geography through sales, grants, or donations in terms of currency (in USD ($) unless otherwise specified).

The revenues for a specified geography are consumption values - that is, they are revenues generated by organizations in the specified geography within the specified market, irrespective of where they are produced. It does not include revenues from resales either further along the supply chain or as part of other products.

The implantable biomaterials market research report is one of a series of new reports that provides implantable biomaterials market statistics, including implantable biomaterials industry global market size, regional shares, competitors with a implantable biomaterials market share, detailed implantable biomaterials market segments, market trends and opportunities, and any further data you may need to thrive in the implantable biomaterials industry. This implantable biomaterials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Major players in the implantable biomaterials market are Evonik Industries AG, Royal DSM, Zimmer Biomet Holdings, Carpenter Technology Corporation, Collagen Matrix, Corbion, BASF SE, Invibio Ltd., and Celanese Corporation.



This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Global Implantable Biomaterials Market

What is the estimated value of the Global Implantable Biomaterials Market?

The Global Implantable Biomaterials Market was estimated to be valued at $113.64 billion in 2022.

What is the growth rate of the Global Implantable Biomaterials Market?

The growth rate of the Global Implantable Biomaterials Market is 12.3%, with an estimated value of $180.87 billion by 2026.

What is the forecasted size of the Global Implantable Biomaterials Market?

The Global Implantable Biomaterials Market is estimated to be worth $180.87 billion by 2026.

Who are the key companies in the Global Implantable Biomaterials Market?

Key companies in the Global Implantable Biomaterials Market include Evonik Industries AG, Royal DSM, Zimmer Biomet Holdings, Carpenter Technology Corporation, Collagen Matrix, Corbion, BASF SE, Invibio Ltd., Celanese Corporation and Cam Bioceramics B.V..

Table of Contents

1. Executive Summary

2. Implantable Biomaterials Market Characteristics

3. Implantable Biomaterials Market Trends And Strategies

4. Implantable Biomaterials Market - Macro Economic Scenario
4.1 COVID-19 Impact On Implantable Biomaterials Market
4.2 Ukraine-Russia War Impact On Implantable Biomaterials Market
4.3 Impact Of High Inflation On Implantable Biomaterials Market

5. Implantable Biomaterials Market Size And Growth
5.1. Global Implantable Biomaterials Historic Market, 2017-2022, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Implantable Biomaterials Forecast Market, 2022-2027F, 2032F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market

6. Implantable Biomaterials Market Segmentation
6.1. Global Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Metallic
  • Ceramic
  • Polymers
  • Natural
6.2. Global Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Dental
  • Cardiovascular
  • Ophthalmology
  • Orthopedic
  • Other Applications
6.3. Global Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty clinics
7. Implantable Biomaterials Market Regional And Country Analysis
7.1. Global Implantable Biomaterials Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Implantable Biomaterials Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific Implantable Biomaterials Market
8.1. Asia-Pacific Implantable Biomaterials Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China Implantable Biomaterials Market
9.1. China Implantable Biomaterials Market Overview
9.2. China Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India Implantable Biomaterials Market
10.1. India Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan Implantable Biomaterials Market
11.1. Japan Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia Implantable Biomaterials Market
12.1. Australia Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia Implantable Biomaterials Market
13.1. Indonesia Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea Implantable Biomaterials Market
14.1. South Korea Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe Implantable Biomaterials Market
15.1. Western Europe Implantable Biomaterials Market Overview
15.2. Western Europe Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK Implantable Biomaterials Market
16.1. UK Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany Implantable Biomaterials Market
17.1. Germany Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France Implantable Biomaterials Market
18.1. France Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Eastern Europe Implantable Biomaterials Market
19.1. Eastern Europe Implantable Biomaterials Market Overview
19.2. Eastern Europe Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Russia Implantable Biomaterials Market
20.1. Russia Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. North America Implantable Biomaterials Market
21.1. North America Implantable Biomaterials Market Overview
21.2. North America Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. USA Implantable Biomaterials Market
22.1. USA Implantable Biomaterials Market Overview
22.2. USA Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. South America Implantable Biomaterials Market
23.1. South America Implantable Biomaterials Market Overview
23.2. South America Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. Brazil Implantable Biomaterials Market
24.1. Brazil Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Middle East Implantable Biomaterials Market
25.1. Middle East Implantable Biomaterials Market Overview
25.2. Middle East Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. Africa Implantable Biomaterials Market
26.1. Africa Implantable Biomaterials Market Overview
26.2. Africa Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. Implantable Biomaterials Market Competitive Landscape And Company Profiles
27.1. Implantable Biomaterials Market Competitive Landscape
27.2. Implantable Biomaterials Market Company Profiles
27.2.1. Evonik Industries AG
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Royal DSM
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Zimmer Biomet Holdings
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Carpenter Technology Corporation
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Collagen Matrix
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Implantable Biomaterials Market

29. Implantable Biomaterials Market Future Outlook and Potential Analysis

30. Appendix
30.1. Abbreviations
30.2. Currencies
30.3. Historic And Forecast Inflation Rates
30.4. Research Inquiries
30.5. About the Publisher
30.6. Copyright And Disclaimer

Executive Summary

Implantable Biomaterials Global Market Report 2023 provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on implantable biomaterials market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Where is the largest and fastest growing market for implantable biomaterials? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The implantable biomaterials market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

Scope

Markets Covered

1) By Material: Metallic; Ceramic; Polymers; Natural
2) By Application: Dental; Cardiovascular; Ophthalmology; Orthopedic; Other Applications
3) By End-user: Hospitals; Ambulatory Surgical Centers; Specialty Clinics

Companies Mentioned: Evonik Industries AG; Royal DSM; Zimmer Biomet Holdings; Carpenter Technology Corporation; Collagen Matrix

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Evonik Industries AG
  • Royal DSM
  • Zimmer Biomet Holdings
  • Carpenter Technology Corporation
  • Collagen Matrix
  • Corbion
  • BASF SE
  • Invibio Ltd.
  • Celanese Corporation
  • Cam Bioceramics B.V.
  • E. I. DU PONT DE NEMOURS AND COMPANY
  • AdvanSource Biomaterials Corporation
  • Wright Medical Technology
  • Berkeley Advanced Biomaterials
  • Collagen solutions Plc
  • Keystone Dental
  • Surgival
  • SBM France
  • 3M
  • Biomet
  • Orthofix Holdings
  • Stryker Corporation
  • KLS martin and Medtronic
  • Arthrex
  • Aap Implantate AG
  • CoorsTek Inc.
  • CeramTec
  • GELITA AG
  • DePuy Synthes Companies
  • Bayer AG

Methodology

Loading
LOADING...